Cite
HARVARD Citation
Senkus-Konefka, E. et al. (n.d.). Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD. European journal of cancer. pp. S19-S20. [Online].